A Study of ZN-c3 in Women With Recurrent or Persistent Uterine Serous Carcinoma

PHASE2RecruitingINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

July 28, 2021

Primary Completion Date

November 30, 2024

Study Completion Date

May 31, 2025

Conditions
Uterine Serous Carcinoma
Interventions
DRUG

ZN-c3

ZN-c3 is an investigational drug.

Trial Locations (52)

2065

ACTIVE_NOT_RECRUITING

Northern Cancer Institute, St Leonards

2139

WITHDRAWN

Concord Repatriation General Hospital, Concord

3000

ACTIVE_NOT_RECRUITING

Peter MacCallum Cancer Centre, Melbourne

3144

ACTIVE_NOT_RECRUITING

Cabrini Hospital Malvern, Malvern

3700

ACTIVE_NOT_RECRUITING

Rustavi Clinic, Rustavi

4032

ACTIVE_NOT_RECRUITING

Icon Cancer Centre- Chermside, Brisbane

4101

ACTIVE_NOT_RECRUITING

Mater Cancer Care Centre, Mater Misericordiae Limited, Brisbane

6000

ACTIVE_NOT_RECRUITING

LTD High Technology Hospital Medcenter, Batumi

6009

ACTIVE_NOT_RECRUITING

Sir Charles Gairdner Hospital, Nedlands

6065

ACTIVE_NOT_RECRUITING

Burnside War Memorial Hospital, Toorak Gardens

10532

ACTIVE_NOT_RECRUITING

Westchester Medical Center, Hawthorne

19140

ACTIVE_NOT_RECRUITING

Temple University Hospital, Philadelphia

20186

ACTIVE_NOT_RECRUITING

Virginia Cancer Specialists, Warrenton

21201

ACTIVE_NOT_RECRUITING

University of Maryland Medical Center, Baltimore

21401

ACTIVE_NOT_RECRUITING

Maryland Oncology Hematology, Annapolis

22908

ACTIVE_NOT_RECRUITING

University of Virginia Cancer Center, Charlottesville

23298

ACTIVE_NOT_RECRUITING

VCU Health System, Richmond

30342

ACTIVE_NOT_RECRUITING

Northside Hospital, Atlanta

30912

ACTIVE_NOT_RECRUITING

Georgia Cancer Center at Augusta University, Augusta

33140

ACTIVE_NOT_RECRUITING

Mount Sinai Medical Center, Miami Beach

33606

ACTIVE_NOT_RECRUITING

University of South Florida, Tampa

34239

ACTIVE_NOT_RECRUITING

Sarasota Memorial Hospital, Sarasota

37236

ACTIVE_NOT_RECRUITING

Ascension St. Thomas Midtown Hospital, Nashville

43210

ACTIVE_NOT_RECRUITING

Ohio State University James Cancer Hospital, Columbus

45219

ACTIVE_NOT_RECRUITING

University of Cincinnati, Cincinnati

45242

ACTIVE_NOT_RECRUITING

Oncology Hematology Care, Cincinnati

ACTIVE_NOT_RECRUITING

Trihealth Cancer Institute, Cincinnati

48659

WITHDRAWN

Revive Clinical Research, Sterling

49503

ACTIVE_NOT_RECRUITING

Corewell Health, Grand Rapids

53226

ACTIVE_NOT_RECRUITING

Medical College of Wisconsin, Milwaukee

64132

ACTIVE_NOT_RECRUITING

HCA Midwest Health Kansas City Research, Kansas City

73104

ACTIVE_NOT_RECRUITING

University of Oklahoma Peggy and Charles Stephenson Cancer Center, Oklahoma City

76104

ACTIVE_NOT_RECRUITING

Texas Oncology Fort Worth Cancer Center, Fort Worth

77089

ACTIVE_NOT_RECRUITING

Texas Oncology Gulf Coast, Houston

78240

ACTIVE_NOT_RECRUITING

Texas Oncology San Antonio, San Antonio

78705

ACTIVE_NOT_RECRUITING

Texas Oncology Austin, Austin

85016

RECRUITING

Honor Health, Phoenix

85711

ACTIVE_NOT_RECRUITING

Arizona Oncology Associates Wilmot HOPE, Tucson

87109

ACTIVE_NOT_RECRUITING

Optimum Clinical Research Group- Women's Oncology, Albuquerque

89511

ACTIVE_NOT_RECRUITING

Center of Hope, Reno

92868

ACTIVE_NOT_RECRUITING

University of California Irvine Medical Center, Orange

94158

ACTIVE_NOT_RECRUITING

University of California San Francisco at Mission Bay, San Francisco

97213

ACTIVE_NOT_RECRUITING

Providence Portland Medical Center, Portland

97227

ACTIVE_NOT_RECRUITING

Northwest Cancer Specialists, Portland

97401

ACTIVE_NOT_RECRUITING

Willamette Valley Cancer Institute, Eugene

99508

ACTIVE_NOT_RECRUITING

Alaska Women's Cancer Care, Anchorage

08901

ACTIVE_NOT_RECRUITING

Rutgers Cancer Institute of New Jersey, New Brunswick

M4N 3M5

ACTIVE_NOT_RECRUITING

Sunnybrook Health Sciences Centre, Toronto

G1R 3S1

ACTIVE_NOT_RECRUITING

Chu de Quebec-Universite, Québec

0112

ACTIVE_NOT_RECRUITING

Acad. Fridon Todua Medical Center, Tbilisi

0144

ACTIVE_NOT_RECRUITING

LTD Innova Medical Center, Tbilisi

0160

ACTIVE_NOT_RECRUITING

LTD TIM-Tbilisi Innova of Medicine, Tbilisi

All Listed Sponsors
lead

K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc

INDUSTRY

NCT04814108 - A Study of ZN-c3 in Women With Recurrent or Persistent Uterine Serous Carcinoma | Biotech Hunter | Biotech Hunter